Submission NameEsperance Healthcare
University NameFlorida State University
Submission DescriptionEsperance Healthcare is a synthetic biology startup providing innovative products for Trimethylaminuria (TMAU) patients. Our E. esperance therapeutic reduces TMA levels, while EsperSense, a Bio-FET breathalyzer, monitors symptoms in real time.
Esperance Healthcare improves the lives of TMAU patients by reducing stigmatizing odor, promoting mental and physical well-being, and restoring dignity. Our solutions foster inclusivity, empower individuals with rare diseases, and advance health equity through accessible, innovative care.
Esperance Healthcare generates profit through subscription-based therapeutic kits (E. esperance) at $30/week, device sales (EsperSense breathalyzer) at $150/unit, and monthly app and sensor subscriptions at $10 each. A multi-channel strategy ensures sustainable, recurring revenue streams.
UN Sustainable Development Goalsgood health and well-being, partnerships for goals, reduced inequalities, industry, innovation, and infrastructure